Mariana Baz

InstitutionResearch Center in Infectious Diseases of the CHU of Québec and Laval University
AddressQuebec
Canada
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 1 Covid-19 publications, with a maximum of 1 publications in January 2021
    All Publications
    Bar chart showing 34 publications over 16 distinct years, with a maximum of 4 publications in 2006 and 2010 and 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Longtin Y, Charest H, Quach C, Savard P, Baz M, Boivin G, Farfard J, Villeneuve J, Roger M, De Serres G. Infectivity of healthcare workers diagnosed with coronavirus disease 2019 (COVID-19) approximately 2 weeks after onset of symptoms: A cross-sectional study. Infect Control Hosp Epidemiol. 2022 Jan; 43(1):102-104. PMID: 33427133.
      Citations: 2     Fields:    Translation:Humans
    2. Baz M, Boivin G. Antiviral Agents in Development for Zika Virus Infections. Pharmaceuticals (Basel). 2019 Jun 29; 12(3). PMID: 31261947.
      Citations: 17     
    3. Baz M, Carbonneau J, Rhéaume C, Cavanagh MH, Boivin G. Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza Virus. Viruses. 2018 11 03; 10(11). PMID: 30400276.
      Citations: 8     Fields:    Translation:AnimalsCells
    4. Bolduc M, Baz M, Laliberté-Gagné MÈ, Carignan D, Garneau C, Russel A, Boivin G, Savard P, Leclerc D. The quest for a nanoparticle-based vaccine inducing broad protection to influenza viruses. Nanomedicine. 2018 11; 14(8):2563-2574. PMID: 30193813.
      Citations: 8     Fields:    Translation:AnimalsCells
    5. Tu V, Abed Y, Fage C, Baz M, Boivin G. Impact of R152K and R368K neuraminidase catalytic substitutions on in vitro properties and virulence of recombinant A(H1N1)pdm09 viruses. Antiviral Res. 2018 06; 154:110-115. PMID: 29674164.
      Citations: 3     Fields:    Translation:AnimalsCells
    6. Piret J, Carbonneau J, Rhéaume C, Baz M, Boivin G. Predominant role of IPS-1 over TRIF adaptor proteins in early innate immune response against Zika virus in mice. J Gen Virol. 2018 02; 99(2):209-218. PMID: 29297844.
      Citations: 4     Fields:    Translation:AnimalsCells
    7. Boonnak K, Matsuoka Y, Wang W, Suguitan AL, Chen Z, Paskel M, Baz M, Moore I, Jin H, Subbarao K. Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses. J Virol. 2017 08 01; 91(15). PMID: 28490598.
      Citations: 4     Fields:    Translation:AnimalsCells
    8. Baz M, Goyette N, Griffin BD, Kobinger GP, Boivin G. In vitro susceptibility of geographically and temporally distinct Zika viruses to favipiravir and ribavirin. Antivir Ther. 2017; 22(7):613-618. PMID: 28694390.
      Citations: 11     Fields:    Translation:HumansAnimalsCells
    9. Retamal M, Abed Y, Rhéaume C, Baz M, Boivin G. In vitro and in vivo evidence of a potential A(H1N1)pdm09 antigenic drift mediated by escape mutations in the haemagglutinin Sa antigenic site. J Gen Virol. 2017 Jun; 98(6):1224-1231. PMID: 28631598.
      Citations:    Fields:    Translation:HumansAnimalsCells
    10. Stephen P, Baz M, Boivin G, Lin SX. Structural Insight into NS5 of Zika Virus Leading to the Discovery of MTase Inhibitors. J Am Chem Soc. 2016 12 21; 138(50):16212-16215. PMID: 27998085.
      Citations: 20     Fields:    Translation:Cells
    11. Baz M, Paskel M, Matsuoka Y, Zengel JR, Cheng X, Treanor JJ, Jin H, Subbarao K. A Single Dose of an Avian H3N8 Influenza Virus Vaccine Is Highly Immunogenic and Efficacious against a Recently Emerged Seal Influenza Virus in Mice and Ferrets. J Virol. 2015 Jul; 89(13):6907-17. PMID: 25903333.
      Citations: 4     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    12. Baz M, Subbarao K. An addition to treatment options for avian influenza A H5N1? Lancet Infect Dis. 2015 Mar; 15(3):251-3. PMID: 25662593.
      Citations:    Fields:    Translation:HumansCells
    13. Baz M, Paskel M, Matsuoka Y, Zengel J, Cheng X, Treanor JJ, Jin H, Subbarao K. A live attenuated equine H3N8 influenza vaccine is highly immunogenic and efficacious in mice and ferrets. J Virol. 2015 Feb; 89(3):1652-9. PMID: 25410860.
      Citations: 6     Fields:    Translation:AnimalsCells
    14. Pizzorno A, Abed Y, Plante PL, Carbonneau J, Baz M, Hamelin MÈ, Corbeil J, Boivin G. Evolution of oseltamivir resistance mutations in Influenza A(H1N1) and A(H3N2) viruses during selection in experimentally infected mice. Antimicrob Agents Chemother. 2014 Nov; 58(11):6398-405. PMID: 25114143.
      Citations: 8     Fields:    Translation:AnimalsCells
    15. Chen Z, Baz M, Lu J, Paskel M, Santos C, Subbarao K, Jin H, Matsuoka Y. Development of a high-yield live attenuated H7N9 influenza virus vaccine that provides protection against homologous and heterologous H7 wild-type viruses in ferrets. J Virol. 2014 Jun; 88(12):7016-23. PMID: 24719414.
      Citations: 37     Fields:    Translation:HumansAnimalsCells
    16. Baz M, Paskel M, Matsuoka Y, Zengel J, Cheng X, Jin H, Subbarao K. Replication and immunogenicity of swine, equine, and avian h3 subtype influenza viruses in mice and ferrets. J Virol. 2013 Jun; 87(12):6901-10. PMID: 23576512.
      Citations: 14     Fields:    Translation:AnimalsCells
    17. Baz M, Papenburg J, Hamelin ME, Ouakki M, Skowronski DM, De Serres G, Boivin G. Seroconversion to seasonal influenza viruses after A(H1N1)pdm09 virus infection, Quebec, Canada. Emerg Infect Dis. 2012 Jul; 18(7):1132-4. PMID: 22710312.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    18. Baz M, Samant M, Zekki H, Tribout-Jover P, Plante M, Lanteigne AM, Hamelin ME, Mallett C, Papadopoulou B, Boivin G. Effects of different adjuvants in the context of intramuscular and intranasal routes on humoral and cellular immune responses induced by detergent-split A/H3N2 influenza vaccines in mice. Clin Vaccine Immunol. 2012 Feb; 19(2):209-18. PMID: 22190392.
      Citations: 20     Fields:    Translation:AnimalsCellsPHPublic Health
    19. Papenburg J, Baz M, Hamelin MÈ, Rhéaume C, Carbonneau J, Ouakki M, Rouleau I, De Serres G, Boivin G. Evaluation of serological diagnostic methods for the 2009 pandemic influenza A (H1N1) virus. Clin Vaccine Immunol. 2011 Mar; 18(3):520-2. PMID: 21228145.
      Citations: 15     Fields:    Translation:HumansCells
    20. Hamelin ME, Baz M, Bouhy X, Beaulieu E, Dubé K, Mallett C, Boivin G. Reduced airborne transmission of oseltamivir-resistant pandemic A/H1N1 virus in ferrets. Antivir Ther. 2011; 16(5):775-9. PMID: 21817200.
      Citations: 12     Fields:    Translation:AnimalsCellsPHPublic Health
    21. Tremblay CL, Rouleau D, Fortin C, Toma E, Sylla M, Cyr L, Cote S, Baz M, Sampalis J, Trautman L, Sékaly RP, Boivin G. Immunogenicity and tolerability of an inactivated and adjuvanted pandemic H1N1 influenza vaccine, in HIV-1-infected patients. Vaccine. 2011 Feb 04; 29(7):1359-63. PMID: 21185423.
      Citations: 12     Fields:    Translation:HumansCells
    22. Papenburg J, Baz M, Hamelin MÈ, Rhéaume C, Carbonneau J, Ouakki M, Rouleau I, Hardy I, Skowronski D, Roger M, Charest H, De Serres G, Boivin G. Household transmission of the 2009 pandemic A/H1N1 influenza virus: elevated laboratory-confirmed secondary attack rates and evidence of asymptomatic infections. Clin Infect Dis. 2010 Nov 01; 51(9):1033-41. PMID: 20887206.
      Citations: 62     Fields:    Translation:HumansCells
    23. Hamelin ME, Baz M, Abed Y, Couture C, Joubert P, Beaulieu E, Bellerose N, Plante M, Mallett C, Schumer G, Kobinger GP, Boivin G. Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets. PLoS Pathog. 2010 Jul 22; 6(7):e1001015. PMID: 20661429.
      Citations: 56     Fields:    Translation:AnimalsCells
    24. Baz M, Abed Y, Simon P, Hamelin ME, Boivin G. Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses. J Infect Dis. 2010 Mar; 201(5):740-5. PMID: 20100088.
      Citations: 62     Fields:    Translation:HumansAnimalsCells
    25. Baz M, Abed Y, Papenburg J, Bouhy X, Hamelin ME, Boivin G. Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis. N Engl J Med. 2009 Dec 03; 361(23):2296-7. PMID: 19907034.
      Citations: 89     Fields:    Translation:HumansCellsPHPublic Health
    26. Abed Y, Baz M, Boivin G. A novel neuraminidase deletion mutation conferring resistance to oseltamivir in clinical influenza A/H3N2 virus. J Infect Dis. 2009 Jan 15; 199(2):180-3. PMID: 19046066.
      Citations: 15     Fields:    Translation:HumansCells
    27. Baz M, Abed Y, Nehmé B, Boivin G. Activity of the oral neuraminidase inhibitor A-322278 against the oseltamivir-resistant H274Y (A/H1N1) influenza virus mutant in mice. Antimicrob Agents Chemother. 2009 Feb; 53(2):791-3. PMID: 19015327.
      Citations: 4     Fields:    Translation:AnimalsCells
    28. Denis J, Acosta-Ramirez E, Zhao Y, Hamelin ME, Koukavica I, Baz M, Abed Y, Savard C, Pare C, Lopez Macias C, Boivin G, Leclerc D. Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform. Vaccine. 2008 Jun 25; 26(27-28):3395-403. PMID: 18511159.
      Citations: 74     Fields:    Translation:AnimalsCells
    29. Abed Y, Nehmé B, Baz M, Boivin G. Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes. Antiviral Res. 2008 Feb; 77(2):163-6. PMID: 17919743.
      Citations: 22     Fields:    Translation:HumansCells
    30. Baz M, Abed Y, Boivin G. Characterization of drug-resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivir. Antiviral Res. 2007 May; 74(2):159-62. PMID: 17137644.
      Citations: 29     Fields:    Translation:AnimalsCells
    31. Baz M, Abed Y, McDonald J, Boivin G. Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child. Clin Infect Dis. 2006 Dec 15; 43(12):1555-61. PMID: 17109288.
      Citations: 82     Fields:    Translation:HumansCells
    32. Goñi N, Baz M, Ruchansky D, Coppola L, Russi J, Cristina J. Influenza B viruses isolated in Uruguay during the 2002-2005 seasons: genetic relations and vaccine strain match. Virus Res. 2007 Jan; 123(1):100-4. PMID: 16987563.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    33. Abed Y, Baz M, Boivin G. Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic backgrounds. Antivir Ther. 2006; 11(8):971-6. PMID: 17302366.
      Citations: 70     Fields:    Translation:HumansAnimalsCells
    34. Boivin G, Baz M, Côté S, Gilca R, Deffrasnes C, Leblanc E, Bergeron MG, Déry P, De Serres G. Infections by human coronavirus-NL in hospitalized children. Pediatr Infect Dis J. 2005 Dec; 24(12):1045-8. PMID: 16371863.
      Citations: 9     Fields:    Translation:HumansCells